A phase II trial of letrozole in combination with bevacizumab, an anti-VEGF antibody, in patients with hormone receptor-positive metastatic breast cancer Meeting Abstract
| Authors: | Traina, T. A.; Dickler, M. N.; Caravelli, J. F.; Yeh, B. M.; Brogi, E.; Panageas, K.; Flores, S. A.; Norton, L.; Park, J.; Hudis, C.; Rugo, H. |
| Abstract Title: | A phase II trial of letrozole in combination with bevacizumab, an anti-VEGF antibody, in patients with hormone receptor-positive metastatic breast cancer |
| Meeting Title: | 28th Annual San Antonio Breast Cancer Symposium (SABCS) |
| Journal Title: | Breast Cancer Research and Treatment |
| Volume: | 94 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2005 Dec 8-11 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0167-6806 |
| Publisher: | Springer |
| Date Published: | 2005-02-01 |
| Start Page: | S93 |
| End Page: | S94 |
| Language: | English |
| ACCESSION: | WOS:000233407100251 |
| PROVIDER: | wos |
| PUBMED: | 16374922 |
| DOI: | 10.1007/s10549-005-1234-6 |
| Notes: | --- - Meeting Abstract: 2030 - 28th Annual San Antonio Breast Cancer Symposium - DEC 08-11, 2005 - San Antonio, TX - "1" - "Source: Wos" |
Altmetric
Citation Impact
BMJ Impact Analytics
